March 3, 2026Open Access

Metabolic Bulk Volume is an independent prognostic factor and facilitates identifying high risk cases for DLBCL patients treated with the R-CHOP

Key Points

High risk DLBCL patients can be better identified using metabolic bulk volume as a prognostic factor, improving outcomes.
Increased tumor dissemination and total tumor burden combined with metabolic bulk volume significantly aids in risk stratification.
Assessment utilized existing parameters to evaluate the prognostic capabilities of metabolic bulk volume in DLBCL cases.
These findings suggest important implications for treatment planning and patient management in DLBCL, warranting broader application.

Abstract

MBV was an independent prognostic factor for DLBCL patients. The combination of MBV with parameters reflecting tumor dissemination distribution or total tumor burden further improved the risk stratification for staging in DLBCL patients.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Authors

Silu Cui

Panpan Luan

Yuxiao Hu

Journals

Frontiers in Oncology

Actions

Institutions

Jiangsu Province Hospital

Nanjing University of Chinese Medicine

Jiangsu Cancer Hospital

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Metabolic Bulk Volume is an independent prognostic factor and facilitates identifying high risk cases for DLBCL patients treated with the R-CHOP

Key Points

Abstract

Citation Network

Connected Papers

Discussion

Authors

Journals

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion

Cite this study

Also consider